Viatris (VTRS) Dividends Paid - Common (2021 - 2026)
Viatris' (VTRS) quarterly Dividends Paid - Common came in at $139.6 million in Q1 2026, down 2.58% year-on-year from $143.3 million in Q1 2025, and up 1.01% quarter-over-quarter from $138.2 million in Q4 2025.
Viatris (VTRS) Dividends Paid - Common (2021 - 2026) Analysis & Trends
Viatris' Dividends Paid - Common history runs 6 years deep, the most recent figure standing at $139.6 million for Q1 2026.
- On a quarterly basis, Dividends Paid - Common fell 2.58% year-over-year to $139.6 million in Q1 2026; TTM through Mar 2026 was $557.5 million, a 3.09% decrease from a year earlier, with the FY2025 full-year figure at $561.2 million, down 2.37% from the prior year.
- Dividends Paid - Common grew to $139.6 million in Q1 2026 per VTRS's latest filing, from $138.2 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $145.5 million in Q2 2022 and bottomed at $138.2 million in Q4 2025.
- The 5-year median for Dividends Paid - Common is $143.8 million (2023), against an average of $143.1 million.
- Across the five-year window, Dividends Paid - Common rose 9.4% in 2022 and slipped 3.92% in 2025, its largest moves.
- Year by year, Dividends Paid - Common stood at $145.5 million in 2022, then retreated by 1.03% to $144.0 million in 2023, then decreased by 0.49% to $143.3 million in 2024, then fell by 3.56% to $138.2 million in 2025, then rose by 1.01% to $139.6 million in 2026.
- Per Business Quant, the three latest VTRS Dividends Paid - Common figures stand at $139.6 million (Q1 2026), $138.2 million (Q4 2025), and $139.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.92 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 139.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.60 Mn |
| Mar 31, 2026 | 139.60 Mn |
| Dec 31, 2025 | 138.20 Mn |
| Dec 31, 2025 | 138.20 Mn |
| Sep 30, 2025 | 139.90 Mn |
| Sep 30, 2025 | 139.90 Mn |
| Jun 30, 2025 | 139.80 Mn |
| Jun 30, 2025 | 139.80 Mn |
| Mar 31, 2025 | 143.30 Mn |
| Mar 31, 2025 | 143.30 Mn |
| Dec 31, 2024 | 143.30 Mn |
| Dec 31, 2024 | 143.30 Mn |
| Sep 30, 2024 | 143.20 Mn |
| Sep 30, 2024 | 143.20 Mn |
| Jun 30, 2024 | 145.50 Mn |
| Jun 30, 2024 | 145.50 Mn |
| Mar 31, 2024 | 142.80 Mn |
| Mar 31, 2024 | 142.80 Mn |
| Dec 31, 2023 | 144.00 Mn |
| Dec 31, 2023 | 144.00 Mn |